NCT00166530View on ClinicalTrials.gov

EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)

PHASE4CompletedINTERVENTIONAL

Enrollment

367

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

Atherosclerosis

Interventions

DRUG

ezetimibe (+) simvastatin

Vytorin® combination tablet of ezetimibe 10 mg plus simvastatin 20 mg once daily for 12 weeks. Tablets

DRUG

simvastatin

Zocor®; simvastatin 40 mg once daily for 12 weeks. Tablets

DRUG

atorvastatin

20 mg atorvastatin once daily for 12 weeks. Tablets

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00166530 - EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089) | Biotech Hunter | Biotech Hunter